SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-14-343081
Filing Date
2014-09-16
Accepted
2014-09-16 16:22:07
Documents
8
Group Members
VALEANT PHARMACEUTICALS INTERNATIONAL

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 7 TO SCHEDULE 13D d790279dsc13da.htm SC 13D/A 46561
2 EX-99.1 d790279dex991.htm EX-99.1 6615
3 EX-99.2 d790279dex992.htm EX-99.2 14203
4 GRAPHIC g790279ex99_1pg001.jpg GRAPHIC 80083
5 GRAPHIC g790279ex99_1pg002.jpg GRAPHIC 72849
6 GRAPHIC g790279ex99_1pg003.jpg GRAPHIC 77255
7 GRAPHIC g790279ex99_1pg004.jpg GRAPHIC 67449
8 GRAPHIC g790279ex99_1pg005.jpg GRAPHIC 28049
  Complete submission text file 0001193125-14-343081.txt   518694
Mailing Address P.O. BOX 19534 IRVINE CA 92713-9534
Business Address 2525 DUPONT DRIVE IRVINE CA 92612 7142464500
ALLERGAN INC (Subject) CIK: 0000850693 (see all company filings)

IRS No.: 951622442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-40724 | Film No.: 141105669
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filed by) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations